(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA] CTD PMID:31150632 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1312928 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:28688763 17beta-estradiol decreases expression ISO RGD:1604615 6480464 Estradiol results in decreased expression of SLC30A10 mRNA CTD PMID:20106945 , PMID:21632981 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC30A10 mRNA, [Testosterone co-treated with Estradiol] results in increased expression of SLC30A10 mRNA CTD PMID:26496021 , PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC30A10 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312928 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC30A10 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312928 6480464 Tetrachlorodibenzodioxin affects the expression of SLC30A10 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312928 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC30A10 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1604615 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC30A10 mRNA CTD PMID:21632981 , PMID:21998131 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:1312928 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:1312928 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA] CTD PMID:18200517 3-Iodothyronamine affects uptake ISO RGD:1604615 6480464 SLC30A10 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-sulfonyldiphenol increases expression ISO RGD:1312928 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC30A10 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO RGD:1312928 6480464 Fenretinide results in decreased expression of SLC30A10 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC30A10 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC30A10 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1604615 6480464 Aflatoxin B1 affects the expression of SLC30A10 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1604615 6480464 Aflatoxin B1 results in decreased methylation of SLC30A10 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1604615 6480464 Aflatoxin B1 results in decreased expression of SLC30A10 mRNA CTD PMID:21632981 more ... all-trans-retinoic acid decreases expression ISO RGD:1604615 6480464 Tretinoin results in decreased expression of SLC30A10 mRNA CTD PMID:23724009 aristolochic acid increases expression ISO RGD:1604615 6480464 aristolochic acid I results in increased expression of SLC30A10 mRNA CTD PMID:33212167 azathioprine decreases expression ISO RGD:1604615 6480464 Azathioprine results in decreased expression of SLC30A10 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1312928 6480464 Benzo(a)pyrene results in decreased expression of SLC30A10 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1604615 6480464 Benzo(a)pyrene results in increased methylation of SLC30A10 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1604615 6480464 Benzo(a)pyrene affects the methylation of SLC30A10 5' UTR, Benzo(a)pyrene affects the methylation of SLC30A10 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1604615 6480464 Benzo(a)pyrene results in decreased expression of SLC30A10 mRNA CTD PMID:20106945 more ... beta-naphthoflavone decreases expression ISO RGD:1604615 6480464 beta-Naphthoflavone results in decreased expression of SLC30A10 mRNA CTD PMID:31588062 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC30A10 mRNA CTD PMID:26496021 bisphenol A affects expression ISO RGD:1604615 6480464 bisphenol A affects the expression of SLC30A10 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC30A10 mRNA CTD PMID:25181051 , PMID:34947998 calcitriol increases expression ISO RGD:1604615 6480464 Calcitriol results in increased expression of SLC30A10 mRNA, Calcitriol results in increased expression of SLC30A10 protein CTD PMID:27107558 calcitriol multiple interactions ISO RGD:1604615 6480464 [Calcitriol results in increased activity of VDR protein] which results in increased expression of SLC30A10 mRNA, Calcitriol promotes the reaction [[VDR protein binds to RXRA protein] which binds to SLC30A10 promoter] CTD PMID:27107558 carbon nanotube decreases expression ISO RGD:1312928 6480464 Nanotubes, Carbon analog results in decreased expression of SLC30A10 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1312928 6480464 Nanotubes, Carbon results in increased expression of SLC30A10 mRNA CTD PMID:25620056 chromium(6+) affects expression ISO RGD:1312928 6480464 chromium hexavalent ion affects the expression of SLC30A10 mRNA CTD PMID:28472532 ciglitazone multiple interactions ISO RGD:1604615 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of SLC30A10 mRNA, [ciglitazone binds to PPARG protein] which results in increased expression of SLC30A10 mRNA CTD PMID:16197558 copper(II) sulfate decreases expression ISO RGD:1604615 6480464 Copper Sulfate results in decreased expression of SLC30A10 mRNA CTD PMID:19549813 curcumin multiple interactions ISO RGD:1312928 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of SLC30A10 mRNA] CTD PMID:18200517 cyclosporin A decreases expression ISO RGD:1312928 6480464 Cyclosporine results in decreased expression of SLC30A10 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1604615 6480464 Cyclosporine results in decreased expression of SLC30A10 mRNA CTD PMID:20106945 more ... dibenz[a,h]anthracene decreases expression ISO RGD:1312928 6480464 1 more ... CTD PMID:26377693 dorsomorphin multiple interactions ISO RGD:1604615 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC30A10 mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:1312928 6480464 Ethanol affects the splicing of SLC30A10 mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1312928 6480464 Ethanol results in increased expression of SLC30A10 mRNA CTD PMID:34590183 ethylenediaminetetraacetic acid multiple interactions ISO RGD:1604615 6480464 Edetic Acid inhibits the reaction [SLC30A10 gene mutant form results in increased abundance of Manganese] CTD PMID:22926781 ethylenediaminetetraacetic acid increases expression ISO RGD:1604615 6480464 Edetic Acid results in increased expression of SLC30A10 mRNA, Edetic Acid results in increased expression of SLC30A10 protein CTD PMID:22341971 folic acid decreases expression ISO RGD:1312928 6480464 Folic Acid results in decreased expression of SLC30A10 mRNA CTD PMID:25629700 furan increases expression ISO RGD:1312928 6480464 furan results in increased expression of SLC30A10 mRNA CTD PMID:24183702 GW 501516 multiple interactions ISO RGD:1604615 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of SLC30A10 mRNA CTD PMID:16197558 isotretinoin decreases expression ISO RGD:1604615 6480464 Isotretinoin results in decreased expression of SLC30A10 mRNA CTD PMID:20436886 manganese atom decreases abundance ISO RGD:1604615 6480464 SLC30A10 gene SNP results in decreased abundance of Manganese CTD PMID:26628504 manganese atom multiple interactions ISO RGD:1312928 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA, [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein CTD PMID:34590183 manganese atom increases secretion ISO RGD:1604615 6480464 SLC30A10 protein results in increased secretion of Manganese CTD PMID:28860195 manganese atom decreases expression ISO RGD:1312928 6480464 Manganese results in decreased expression of SLC30A10 mRNA CTD PMID:29020610 manganese atom affects transport ISO RGD:1604615 6480464 SLC30A10 gene SNP affects the transport of Manganese CTD PMID:26025379 manganese atom multiple interactions ISO RGD:1604615 6480464 [IL6 protein results in decreased expression of SLC30A10 mRNA] which results in decreased export of Manganese more ... CTD PMID:22926781 , PMID:24576911 manganese atom increases abundance ISO RGD:1604615 6480464 SLC30A10 gene mutant form results in increased abundance of Manganese, SLC30A10 gene SNP results in increased abundance of Manganese CTD PMID:22926781 , PMID:26628504 manganese(0) decreases abundance ISO RGD:1604615 6480464 SLC30A10 gene SNP results in decreased abundance of Manganese CTD PMID:26628504 manganese(0) multiple interactions ISO RGD:1312928 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA, [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein CTD PMID:34590183 manganese(0) increases secretion ISO RGD:1604615 6480464 SLC30A10 protein results in increased secretion of Manganese CTD PMID:28860195 manganese(0) decreases expression ISO RGD:1312928 6480464 Manganese results in decreased expression of SLC30A10 mRNA CTD PMID:29020610 manganese(0) affects transport ISO RGD:1604615 6480464 SLC30A10 gene SNP affects the transport of Manganese CTD PMID:26025379 manganese(0) multiple interactions ISO RGD:1604615 6480464 [IL6 protein results in decreased expression of SLC30A10 mRNA] which results in decreased export of Manganese more ... CTD PMID:22926781 , PMID:24576911 manganese(0) increases abundance ISO RGD:1604615 6480464 SLC30A10 gene mutant form results in increased abundance of Manganese, SLC30A10 gene SNP results in increased abundance of Manganese CTD PMID:22926781 , PMID:26628504 manganese(II) chloride multiple interactions ISO RGD:1312928 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 mRNA, [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC30A10 protein CTD PMID:34590183 methylmercury chloride increases expression ISO RGD:1312928 6480464 methylmercuric chloride results in increased expression of SLC30A10 mRNA CTD PMID:19465457 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1604615 6480464 ATF4 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SLC30A10 mRNA] CTD PMID:28688763 N-methyl-4-phenylpyridinium increases expression ISO RGD:1604615 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC30A10 mRNA CTD PMID:28688763 N-methyl-4-phenylpyridinium decreases response to substance ISO RGD:1604615 6480464 SLC30A10 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:28688763 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of SLC30A10 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:1604615 6480464 Acetaminophen results in decreased expression of SLC30A10 mRNA CTD PMID:29067470 parathion decreases expression ISO RGD:1312928 6480464 Parathion results in decreased expression of SLC30A10 mRNA CTD PMID:34813904 phenobarbital multiple interactions ISO RGD:1312928 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC30A10 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:1312928 6480464 Phenobarbital results in decreased expression of SLC30A10 mRNA CTD PMID:19270015 , PMID:19482888 phenylmercury acetate increases expression ISO RGD:1604615 6480464 Phenylmercuric Acetate results in increased expression of SLC30A10 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1604615 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1604615 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC30A10 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1312928 6480464 pirinixic acid results in decreased expression of SLC30A10 mRNA CTD PMID:20813756 , PMID:23811191 pirinixic acid multiple interactions ISO RGD:1312928 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of SLC30A10 mRNA CTD PMID:20813756 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1312928 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC30A10 mRNA CTD PMID:27413110 quercetin decreases expression ISO RGD:1604615 6480464 Quercetin results in decreased expression of SLC30A10 mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:1604615 6480464 Oxyquinoline results in decreased expression of SLC30A10 mRNA CTD PMID:21632981 reactive oxygen species decreases abundance EXP 6480464 SLC30A10 protein results in decreased abundance of Reactive Oxygen Species CTD PMID:22427991 reactive oxygen species multiple interactions EXP 6480464 [SLC30A10 protein affects the expression of CAT protein] which affects the abundance of Reactive Oxygen Species CTD PMID:22427991 resveratrol multiple interactions ISO RGD:1604615 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC30A10 mRNA CTD PMID:23557933 rifampicin decreases expression ISO RGD:1604615 6480464 Rifampin results in decreased expression of SLC30A10 mRNA CTD PMID:27199754 ritodrine decreases expression ISO RGD:1312928 6480464 Ritodrine results in decreased expression of SLC30A10 mRNA CTD PMID:23370008 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC30A10 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1604615 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1604615 6480464 sodium arsenite results in decreased expression of SLC30A10 mRNA CTD PMID:29301061 testosterone decreases expression ISO RGD:1312928 6480464 Testosterone deficiency results in decreased expression of SLC30A10 mRNA CTD PMID:33848595 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Estradiol] results in increased expression of SLC30A10 mRNA CTD PMID:32741896 tetrachloroethene decreases expression ISO RGD:1312928 6480464 Tetrachloroethylene results in decreased expression of SLC30A10 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC30A10 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC30A10 mRNA CTD PMID:23411599 thyroxine decreases chemical synthesis ISO RGD:1312928 6480464 SLC30A10 gene mutant form results in decreased chemical synthesis of Thyroxine CTD PMID:28860195 trichostatin A increases expression ISO RGD:1604615 6480464 trichostatin A results in increased expression of SLC30A10 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1604615 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA CTD PMID:27188386 tunicamycin increases expression ISO RGD:1604615 6480464 Tunicamycin results in increased expression of SLC30A10 mRNA CTD PMID:28688763 valproic acid affects expression ISO RGD:1312928 6480464 Valproic Acid affects the expression of SLC30A10 mRNA CTD PMID:17963808 vorinostat increases expression ISO RGD:1604615 6480464 vorinostat results in increased expression of SLC30A10 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1604615 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A10 mRNA CTD PMID:27188386 zinc atom affects abundance EXP 6480464 SLC30A10 protein affects the abundance of Zinc CTD PMID:22427991 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of SLC30A10 mRNA CTD PMID:22427991 zinc atom multiple interactions EXP 6480464 [SLC30A10 protein affects the abundance of Zinc] which affects the expression of CDKN1A protein, [SLC30A10 protein affects the abundance of Zinc] which affects the expression of TP53 protein CTD PMID:22427991 zinc atom decreases response to substance ISO RGD:1604615 6480464 SLC30A10 protein results in decreased susceptibility to Zinc CTD PMID:22427991 zinc(0) affects abundance EXP 6480464 SLC30A10 protein affects the abundance of Zinc CTD PMID:22427991 zinc(0) decreases response to substance ISO RGD:1604615 6480464 SLC30A10 protein results in decreased susceptibility to Zinc CTD PMID:22427991 zinc(0) multiple interactions EXP 6480464 [SLC30A10 protein affects the abundance of Zinc] which affects the expression of CDKN1A protein, [SLC30A10 protein affects the abundance of Zinc] which affects the expression of TP53 protein CTD PMID:22427991 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of SLC30A10 mRNA CTD PMID:22427991
